{"_id": "21902503|None", "id": "21902503", "infons": {}, "passages": [{"infons": {"journal": "Pharmacogenomics; 2011 Oct; 12(10) 1493-501. doi:10.2217/pgs.11.91", "year": "2011", "type": "title", "authors": "L Huillier AG, Ing Lorenzini K, Crisinel PA, Rebsamen MC, Fluss J, Korff CM, Barbe RP, Siegrist CA, Dayer P, Posfay-Barbe KM, Desmeules JA", "section": "Title"}, "offset": 0, "text": "ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia.", "sentences": [], "annotations": [{"id": "5", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 0, "length": 5}]}, {"id": "6", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 59, "length": 11}]}, {"id": "7", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 79, "length": 8}]}, {"id": "8", "infons": {"identifier": "114727", "type": "Species"}, "text": "H1N1", "locations": [{"offset": 105, "length": 4}]}, {"id": "9", "infons": {"type": "Disease", "identifier": null, "db": null}, "text": "pandemia", "locations": [{"offset": 113, "length": 8}]}], "relations": []}, {"infons": {"type": "abstract", "section": "Abstract"}, "offset": 123, "text": "AIMS: To examine the safety profile of oseltamivir in children and evaluate the impact of P-glycoprotein polymorphisms on the incidence of neuropsychiatric adverse events (NPAE) in oseltamivir-treated children. SUBJECTS &amp; METHODS: This prospective cohort study was conducted in our tertiary care pediatric hospital (University Hospitals of Geneva, Switzerland) during the H1N1 pandemia, between 1 October 2009 and 31 January 2010. All newborn to 18 year-old patients presenting at the emergency department with a flu-like illness were eligible for inclusion. Adverse events were systematically recorded by pediatricians and/or by parents at home using a diary card, with a 30-day follow-up period. The causality assessment of oseltamivir in NPAE was performed by two clinical pharmacologists. After informed consent, enrolled patients were also genotyped for ABCB1 3435C&gt;T (rs1045642) and 2677G&gt;T/A (rs2032582) polymorphisms. RESULTS: Among the 42 H1N1-infected, oseltamivir-treated children who were genotyped for ABCB1 3435C&gt;T and 2677G&gt;T/A variants, 36% presented NPAE. When examining the association between the diplotype and the development of NPAE, we observed that the frequency of NPAE displayed a 'genotype-trend effect' with the variant and the wild-type subgroups at the two far ends. A total of 11% of the 2677GG-3435CC individuals (wild-type homozygous) presented NPAE, compared with 39% of the individuals being heterozygous for at least one variant allele and 67% of the 2677TT-3435TT individuals (homozygous variants) (p = 0.149, nonsignificant). CONCLUSION: These observations suggest a potential influence of ABCB1 polymorphisms in oseltamivir-related NPAE, maybe as a result of an enhanced permeability of the blood-brain barrier to oseltamivir", "sentences": [], "annotations": [{"id": "30", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 162, "length": 11}]}, {"id": "31", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 177, "length": 8}]}, {"id": "32", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 304, "length": 11}]}, {"id": "33", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 324, "length": 8}]}, {"id": "34", "infons": {"identifier": "MESH:D000249", "type": "Chemical"}, "text": "amp", "locations": [{"offset": 344, "length": 3}]}, {"id": "35", "infons": {"identifier": "114727", "type": "Species"}, "text": "H1N1", "locations": [{"offset": 499, "length": 4}]}, {"id": "36", "infons": {"type": "Disease", "identifier": null, "db": null}, "text": "pandemia", "locations": [{"offset": 504, "length": 8}]}, {"id": "37", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 585, "length": 8}]}, {"id": "38", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 853, "length": 11}]}, {"id": "39", "infons": {"identifier": "9606", "type": "Species"}, "text": "patients", "locations": [{"offset": 953, "length": 8}]}, {"id": "40", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 986, "length": 5}]}, {"id": "41", "infons": {"identifier": "rs1045642", "type": "Mutation", "subtype": "SNP"}, "text": "rs1045642", "locations": [{"offset": 1004, "length": 9}]}, {"id": "42", "infons": {"identifier": "rs2032582", "type": "Mutation", "subtype": "SNP"}, "text": "rs2032582", "locations": [{"offset": 1033, "length": 9}]}, {"id": "43", "infons": {"identifier": "MESH:D007239", "type": "Disease"}, "text": "H1N1-infected", "locations": [{"offset": 1081, "length": 13}]}, {"id": "44", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 1096, "length": 11}]}, {"id": "45", "infons": {"identifier": "9606", "type": "Species"}, "text": "children", "locations": [{"offset": 1116, "length": 8}]}, {"id": "46", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1148, "length": 5}]}, {"id": "47", "infons": {"identifier": "5243", "type": "Gene", "ncbi_homologene": "55496"}, "text": "ABCB1", "locations": [{"offset": 1766, "length": 5}]}, {"id": "48", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 1789, "length": 11}]}, {"id": "49", "infons": {"identifier": "MESH:D053139", "type": "Chemical"}, "text": "oseltamivir", "locations": [{"offset": 1891, "length": 11}]}], "relations": []}], "relations": [], "pmid": 21902503, "pmcid": null, "created": {"$date": 1592598838791}, "accessions": ["disease@MESH:D007239", "chemical@MESH:D053139", "species@9606", "species@114727", "mutation@rs2032582", "gene@5243", "mutation@rs1045642", "chemical@MESH:D000249"], "journal": "Pharmacogenomics", "year": 2011, "authors": ["L Huillier AG", "Ing Lorenzini K", "Crisinel PA", "Rebsamen MC", "Fluss J", "Korff CM", "Barbe RP", "Siegrist CA", "Dayer P", "Posfay-Barbe KM", "Desmeules JA"]}